electronics >> proteomics
Banking & analyzing proteins for scientific breakthroughs.
why Nautilus Biotechnology?
Sujal Patel is a decade-long defy ally and current defy Sage who's now CEO of Nautilus. Poised to be a disruptive, multi-billion dollar company, Nautilus is building technology on scientific research and intellectual property. Defy invested in Nautilus alongside our friends at A16Z, Vulcan and Madrona. The company went public on NASDAQ in June 2021.